DNp63 is overexpressed in squamous carcinomas where it is associated with proliferation and is believed to enhance cell growth by blocking p53-mediated transactivation. In normal epithelium, DNp63a protein expression is abundant in basal cells and decreases with differentiation. To explore the biological consequences of DNp63a overexpression in relation to squamous carcinogenesis, we evaluated its effect on normal squamous differentiation and p53 transactivation function in keratinocytes. Forced overexpression of DNp63a in primary murine keratinocytes in vitro inhibits morphological differentiation induced by elevated extracellular [Ca 2 þ ], abrogates Ca 2 þ -induced growth arrest, and blocks expression of maturation-specific proteins keratin 10 and filaggrin. This suggests that DNp63 overexpression in squamous carcinomas may serve to maintain the basal cell phenotype and promote cell survival. DNp63a blocks transactivation of p53 responsive reporter constructs mediated by endogenous or exogenous p53 at 17 h postinfection, as expected. However, at 41 h, when p53-mediated transactivation is diminished, DNp63a enhances transactivation of these reporter constructs by 2.2-12-fold over control. Maximal DNp63a-induced transactivation requires intact p53 responsive elements, but is independent of cellular p53 status. This positive transcriptional function of DNp63a appears to be cell-type specific, as it is not observed in primary dermal fibroblasts or Saos-2 cells. These findings support DNp63a as a master regulator of keratinocyte differentiation, and suggest a novel function of this protein in the maintenance of epithelial homeostasis.
Introduction
The p53 homologues, p63 and p73, were identified on the basis of their structural similarity to the p53 tumor suppressor protein (Kaghad et al., 1997; Osada et al., 1998; Senoo et al., 1998; Trink et al., 1998; Yang et al., 1998 Yang et al., , 2002 Lee et al., 1999; Bamberger and Schmale, 2001; Irwin and Kaelin, 2001; Moll et al., 2001) . Both p63 and p73 are expressed as multiple isoforms arising from alternative promoter usage and c-terminal alternative splicing (Osada et al., 1998; Senoo et al., 1998; Yang et al., 1998; Bamberger and Schmale, 2001; Moll et al., 2001; Yang et al., 2002) . TA isotypes contain a transactivation domain homologous to that of p53 and can mimic p53 transactivation function, whereas DN isotypes lack this domain and block reporter activity mediated by p53 and TA-p63 (Yang et al., 1998) .
The p63 gene is critical for the development of stratified squamous epithelium, and DNp63a is the predominant isotype within this tissue (Mills et al., 1999; Parsa et al., 1999; Yang et al., 1999) . Recent studies of squamous cell cancers demonstrate amplification of the p63 gene locus and overexpression of p63, particularly DNp63, at the protein and mRNA levels (Crook et al., 2000; Hibi et al., 2000; Yamaguchi et al., 2000; Glickman et al., 2001; Senoo et al., 2001; Hu et al., 2002; Pelosi et al., 2002) . This overexpression is primarily associated with the proliferative compartment (Parsa et al., 1999; Pelosi et al., 2002; Reis-Filho et al., 2002) , but its relevance remains unclear. Targeted overexpression of DNp63a blocks UVB-induced apoptosis of transgenic mouse epidermal keratinocytes (Liefer et al., 2000) , a p53-dependent process (Ziegler et al., 1994) , and this and other studies suggest that overexpression of DNp63a could contribute to aberrant growth regulation associated with neoplastic development or progression in epithelial tissues by blocking p53 function (Crook et al., 2000; Liefer et al., 2000) . In murine keratinocytes, loss of p53 promotes the progression of experimentally induced papillomas to undifferentiated squamous cell carcinomas (Kemp et al., 1993; Weinberg et al., 1994) .
Many studies aimed at defining the functions of specific p63 isotypes have been performed in nonepithelial assay systems, yet endogenous DNp63 expression is restricted primarily to epithelial tissues (Osada et al., 1998; Yang et al., 1998; Bamberger and Schmale, 2001; Dellavalle et al., 2001; Di Como et al., 2002; Serber et al., 2002) . Therefore, we utilized primary murine epidermal keratinocytes as a model of squamous epithelium to challenge the effect of DNp63a overexpression on growth regulation, differentiation potential, and p53 function in relation to squamous carcinogenesis. In this study, we demonstrate that overexpression of DNp63a dramatically blocks morphological differentiation and the corresponding differentiation-specific protein expression induced by elevated [Ca 2 þ ] in vitro, while at the same time abrogating differentiation-associated growth arrest. In addition to its ability to block transactivation by both exogenous and endogenous p53, we show that DNp63a can activate transcription from p53 responsive reporter constructs in keratinocytes. This transactivation is cell-type specific, time-and consensus sequence-dependent and independent of cellular p53 status. These results demonstrate that DNp63a can function as a master regulator of the keratinocyte differentiation program, and suggest a novel mechanism for DNp63a action.
Results
In normal epithelium, endogenous DNp63a is highly expressed in the proliferating compartment (Yang et al., 1998; Parsa et al., 1999) . In vitro, growth arrest and induction of keratinocyte differentiation can be triggered by elevating extracellular [Ca 2 þ ] to 40.10 mm (Yuspa et al., 1989) . At 24 h following the introduction of the calcium trigger, we observed a decline in endogenous DNp63a protein expression (Figure 1a) , consistent with reported observations in vivo (Yang et al., 1998; Parsa et al., 1999) . To model the DNp63 overexpression observed in human squamous cell carcinomas, we used adenoviral transduction to introduce DNp63a (Ad-DNp63a), or b-galactosidase (Ad-bgal) as a control, into cultured murine keratinocytes. Effects on morphology, cell cycle regulation and biochemical responses were evaluated under conditions that normally maintain keratinocyte proliferation or induce differentiation. As shown in Figure 1b , overexpression of Ad-DNp63a inhibits the onset of differentiation-associated squamous morphology that is observed in Ad-b-gal control keratinocytes following exposure to 0.12 mm Ca 2 þ . DNp63a overexpression also abrogates the growth arrest normally associated with differentiation, as determined by FACS analysis of BrdU pulsed keratinocytes. As shown in Figure 2a , the S phase population of control keratinocytes expressing Ad-b-gal decreased on average 43% following 24 h of exposure to 0.12 mm Ca 2 þ , whereas no parallel reduction in the S phase population was observed in keratinocytes overexpressing Ad-DNp63a under identical conditions. These changes in the calcium response of keratinocytes overexpressing Ad-DNp63a, as assessed by morphology and cell cycle analysis, are associated with altered expression profiles of differentiation-specific proteins. Western analysis demonstrated that overexpression of Ad-DNp63a blocks Ca 2 þ -induced expression of keratin 10, a spinous layer protein, as well as the granular layer protein filaggrin (Figure 2b ). No effect was observed on the induction of keratin 1, which is expressed prior to keratin 10. Expression of filaggrin remained blocked throughout the time course evaluated, whereas levels of keratin 10 began to increase at later timepoints, corresponding with reduced levels of adenovirally driven DNp63a expression (Figure 2b ). This suggests that the decrease in AdDNp63a levels is permissive for keratin 10 expression. Taken together, these data suggest a role for overexpressed DNp63a in squamous carcinogenesis in maintaining a basal cell phenotype and promoting cell survival.
Previous studies have suggested that DNp63 overexpression may be oncogenic because of its ability to block activity of the tumor suppressor p53 (Yang et al., 1998; Crook et al., 2000; Liefer et al., 2000) . Therefore, we examined the effect of DNp63a overexpression on transactivation mediated by both endogenous and exogenous p53 in keratinocytes. Endogenous p53 activity has been shown to increase when keratinocytes are induced to differentiate by exposure to elevated (Weinberg et al., 1995) . Since increases in p53 activity are inversely correlated with DNp63a levels (see Figure 1a) , we speculated that endogenous p53 activity is modulated by DNp63a. Therefore, we examined the effect of forced overexpression of DNp63a on the transactivation of p53 responsive reporters. Consistent with previous observations (Weinberg et al., 1995) , low levels of endogenous p53 transcriptional activity are detectable in proliferating Ad-b-gal control cultures, as detected with the p53-responsive PG 13 luc reporter construct, and these levels increase in the presence of 1.2 mm Ca 2 þ (Figure 3a) . Similar results were obtained using the p53 responsive BDS-2 reporter construct (Figure 3b) . Surprisingly, no inhibition of reporter gene activity was observed at the same timepoint in cultures overexpressing DNp63a under either Ca 2 þ concentration (Figure 3a, b) . Under low Ca 2 þ conditions (0.05 mm), DNp63a overexpression caused a 2.96-fold increase in PG 13 luc and an 11.7-fold increase in BDS-2 reporter activity relative to Ad-b-gal controls. In 1.2 mm Ca 2 þ , a 2.2-fold increase in PG 13 luc and a 10.7-fold increase in BDS-2 reporter gene activity was seen in cultures expressing Ad-DNp63a as compared to Ad-b-gal controls (Figure 3a , b). The greater activity levels observed in 1.2 mm compared to 0.05 mm Ca 2 þ can be explained by increases in the adenovirally driven DNp63a protein expression (not shown). Transactivation with DNp63a was observed regardless of whether the adenovirus was introduced prior to or after transfection with the reporter construct, and was also seen following cotransfection of a DNp63a expression Figure 2 DNp63a overexpression blocks differentiation-associated growth arrest and differentiation-specific protein expression. Keratinocytes were infected with adenovirus encoding DNp63a or b-galactosidase. At 17 h postinfection, cultures were either maintained in medium containing 0.05 mm Ca 2 þ or induced to differentiate by increasing extracellular [Ca 2 þ ] to 0.12 mm for 24 h. (a) Cultures were pulsed with 10 mm BrdU for the final 4 h prior to harvesting, and the S phase population of each sample was determined using FACS analysis. Values in parenthesis indicate number of replicates. Data are presented as mean7s.d. for each of three independent experiments. As shown in bold, the average S-phase population in b-gal control cultures decreased by 43% following exposure to 0.12 mm Ca 2 þ . No reduction in the S phase population was observed in keratinocytes overexpressing DNp63a. (b) Wholecell lysates were harvested 11.5, 23, 32 or 48 h post-Ca 2 þ trigger. Top panel: membranes were probed sequentially with antibodies directed to filaggrin, keratin 1, and keratin 14. Bottom panel: replicate Western blots of lysates described above were probed sequentially with antibodies directed to keratin 10, b-galactosidase, DNp63a, and keratin 14. For each antibody, both treatment groups were exposed to ECL reagent for the same length of time. Induction of differentiation-specific proteins filaggrin and keratin 10, but not keratin 1, is blocked by DNp63a overexpression DNp63a and gene expression in keratinocytes KE King et al vector with PG 13 luc (results not shown). To address whether the p53 consensus sequence is required for this activity, reporter constructs encoding mutations in the p53 responsive elements (Kern et al., 1991; Hermeking et al., 1997) were introduced into keratinocytes overexpressing Ad-DNp63a or Ad-b-gal. These constructs showed diminished activity relative to constructs containing the wild-type consensus sequence (Figure 3c, d) , thus an intact p53 consensus binding sequence participates in maximal DNp63a-mediated transactivation activity.
As a result of the unexpected effect of DNp63a on transactivation of reporter genes in keratinocytes, the experiment was repeated in Saos-2 cells as a negative control. Consistent with previously reported data (Yang et al., 1998) , Ad-DNp63a did not activate expression from PG 13 luc in this cell line, while transactivation was induced by Ad-p53 (Figure 3e ). Coinfection of Saos-2 cells with adenoviruses encoding DNp63a and p53 confirmed that DNp63a blocks transactivation of PG 13 luc by exogenous p53 in Saos-2 cells, as described previously (Figure 3f) . The difference in the transactiva- tion activity driven by DNp63a between these cell types is not because of varying Ad-DNp63a expression levels, as Saos-2 cells and keratinocytes express similar levels of DNp63a following adenoviral transduction (Figure 4a) . To confirm the cell-type-specific nature of AdDNp63a-mediated transactivation, we assayed primary fibroblasts derived from the same tissue as keratinocyte preparations, thus alleviating differences because of species specificity or acquired genetic changes reflecting the long-term culture or origin of Saos-2 cells. Infecting fibroblasts at the same adenoviral titers used for keratinocytes and Saos-2 cells resulted in relatively lower initial levels and less stable expression of AdDNp63a (Figure 4a ). Increasing the titer 10-fold boosted expression levels of Ad-DNp63a in the fibroblasts above those observed in the other cell types (Figure 4b ).
DNp63a has been shown to be degraded by caspases (Ratovitski et al., 2001) . Therefore to further enhance DNp63a protein expression fibroblasts were cultured in the presence of the caspase inhibitor Z-VAD-FMK, which extended detectable expression of DNp63a through 72 h postinfection (Figure 4c ). Regardless of Ad-DNp63a expression levels achieved, transactivation of the PG 13 luc reporter construct was never observed in fibroblasts at any timepoint evaluated (Figure 4d) . Thus, the lack of transactivation in fibroblasts is not simply because of differing expression levels in this cell type, but more likely reflects cellular background and celltype-specific functional differences in DNp63a activity.
To determine whether DNp63a is unique among the p63 isoforms in its differential activity across cell types, similar assays were performed with the TAp63a and Figure 4 Transactivation by DNp63a is cell-type specific. (a-c) Keratinocytes, Saos-2 cells, and dermal fibroblasts were infected with adenovirus encoding DNp63a or b-gal and harvested at 17, 41, 72 and 96 h postinfection for Western blot analysis. Membranes were probed with antibodies to p63 (4A4) and a-actin. (a) All panels were exposed to ECL reagent for the same length of time. Adenoviral DNp63a levels expression levels are similar in keratinocytes and Saos-2 cells, but are lower in fibroblasts. (b) Fibroblast cultures were infected with 10 Â higher adenoviral titer than keratinocytes, and panels were exposed for the same length of time. Increasing adenoviral titer 10-fold enhances DNp63a protein expression in fibroblasts. (c) Fibroblasts were infected with DNp63a adenovirus and incubated with and without Z-VAD-FMK (40 mg/ml) up to timepoints indicated. Z-VAD-FMK stabilizes DNp63a expression in fibroblasts. (d) Fibroblasts were transfected with PG 13 luc and infected with adenoviruses encoding b-gal, p53, and DNp63a. Cells were maintained in the presence or absence of Z-VAD-FMK (40 mg/ml) and harvested 17, 41 and 72 h postinfection for luciferase assays. Even with enhanced expression levels, no reporter activity was seen with DNp63a overexpression in fibroblasts DNp63a and gene expression in keratinocytes KE King et al TAp63g isotypes. TAp63a failed to drive PG 13 luc reporter gene expression in Saos-2 cells, presumably as a result of autoinhibition arising from the a-terminus (Yang et al., 1998 Serber et al., 2002) . Consistent with results in Saos-2 cells, TAp63a did not transactivate the p53-responsive reporter PG 13 luc in keratinocytes (results not shown). The p63 isotype TAp63g, which transactivates PG 13 luc in Saos-2 cells, also induced transactivation in keratinocytes (results not shown).
As shown in Figure 3 , Ad-DNp63a exhibits strong transactivational activity in keratinocytes at 41 h postinfection, but no blocking effect on endogenous p53 activity is apparent. To clarify whether the blocking effect of Ad-DNp63a on endogenous p53 activity was masked by its strong transactivational activity, PG 13 luc transfected keratinocytes were infected with adenovirus encoding p53 or DNp63a together or in combination with Ad-b-gal control. These experiments revealed that Ad-p53 and Ad-DNp63a exhibit distinct time courses of transactivational activity in this system, and explain why blocking of p53 by DNp63a was not initially observed ( Figure 5a ). Transactivation of PG 13 luc by Ad-p53 is evident as early as 17 h postinfection and declines by Blocking of Ad-p53-mediated transactivation by AdDNp63a can be discerned at 17 h, a time prior to the onset of Ad-DNp63a-mediated transactivation (Figure 5a ). When the initial assay to evaluate the effect of Ad-DNp63a on endogenous p53 activity (Figure 3a , b) was repeated at 17 h, it became clear that Ad-DNp63a also blocks transactivation induced by endogenous p53 at this earlier timepoint (Figure 5b ). This dominantnegative activity subsides by 41 h postinfection, when transactivation of the PG 13 luc reporter vector becomes apparent in the cells overexpressing Ad-DNp63a (Figure 5b ). Thus, p53 and DNp63a exhibit differential time courses of transactivation activity and DNp63a does block p53 transactivation function at early timepoints in this assay.
To further explore the relation between p53 and DNp63a-induced transactivation in keratinocytes, assays were performed in keratinocytes of varying p53 gene dosages. No difference was seen in the timing or degree of transactivation in keratinocytes from p53
þ /À and p53 À/À mice following introduction of AdDNp63a (Figure 5c ). Thus, cellular p53 status neither interferes with nor contributes to transactivation modulated by DNp63a in keratinocytes.
The a-carboxy terminus of TAp63a has been implicated in the autoinhibition of transactivational activity mediated by TAp63a (Serber et al., 2002; Yang et al., 2002) . To determine whether this domain also influences transactivation mediated by DNp63a, we introduced p40, a DNp63 isotype that is truncated immediately after the oligomerization domain (Trink et al., 1998) . In the absence of the a carboxyl terminus, DNp63 induces PG 13 luc transactivation at 17 h postinfection (Figure 5d ), potentially reflecting loss of a negative regulatory domain within the carboxyl terminus (Yang et al., 1998; Serber et al., 2002) . Additionally, this demonstrates that the a-terminus is not required for DNp63-mediated transactivation in keratinocytes.
Discussion
Genetic deletion studies demonstrated that the p63 gene is critical for the development of squamous epithelium, but the relative contribution of the individual isotypes is still unclear (Mills et al., 1999; Yang et al., 1999) . DNp63, the predominant isotype in proliferating epithelium, is overexpressed in squamous cell carcinomas (Crook et al., 2000; Hibi et al., 2000; Senoo et al., 2001; Hu et al., 2002) . To determine the functional significance of this overexpression, we adenovirally introduced DNp63a into keratinocytes of squamous epithelium and evaluated the capacity of these cells to respond to differentiation-inducing Ca 2 þ signals in vitro. Overexpression of DNp63a dramatically inhibited the onset of squamous morphology and blocked Ca 2 þ -induction of differentiation-specific proteins keratin 10 and filaggrin (Figures 1b, 2b) . Additional evidence of a role for DNp63a in the maintenance of the proliferative cell population is derived from cell cycle analyses, in which DNp63a overexpression in keratinocytes was shown to abrogate the Ca 2 þ -induced reduction in the S phase population. The present findings suggest that a decrease in DNp63a expression levels is necessary for normal differentiation to occur and that overexpression of DNp63 within tumors may maintain the proliferative state of neoplastic cells. This is consistent with previous studies of squamous cell carcinomas, in which overexpression of DNp63 is localized to the undifferentiated cells and is removed from areas of terminal differentiation (Parsa et al., 1999; Reis-Filho et al., 2002) .
Both p73 and p53 null mice develop with no apparent epidermal abnormalities (Donehower et al., 1992; Weinberg et al., 1995; , suggesting that it may be the balance between the DN and TA isotypes of p63 that is critical for normal keratinocyte growth regulation. The blocking effect of DNp63a on TAp63-mediated transcription may contribute to the aberrant growth arrest observed in these studies. For example, the CDK inhibitor p21 WAF1 was initially identified as the product of a p53-responsive gene, however elevation of p21 WAF1 levels in conjunction with differentiation-associated growth arrest is independent of p53 (Missero et al., 1995; Weinberg et al., 1995) . We speculate that p21 WAF1 is a target of transactivation by endogenous TAp63, and that this transactivation is blocked in the presence of elevated levels of DNp63a.
The undeveloped epidermis and perinatal lethality of p63 null mice preclude the examination of keratinocyte growth regulation and differentiation in a cellular background devoid of p63, and the development of conditional transgenic models will be necessary to better understand the in vivo roles of each of the isotypes. The present studies offer important data on the biological effects of the DNp63a isotype and the interplay between the family members in a relevant cellular context. These cell culture studies also help to clarify the importance of the sequential relation between DNp63a expression levels and the differentiation trigger. In the experiment shown in Figure 2b , the Ca 2 þ trigger was introduced at a time when high levels of exogenous DNp63a protein were already expressed. When the differentiation trigger was introduced concomitant with the cDNA for DNp63a but prior to elevated protein levels, the morphological effect on differentiation was still apparent but less pronounced (results not shown). These findings suggest that induction of DNp63a expression coincident with or subsequent to the earliest differentiation trigger may not be sufficient to block the consequential differentiation response, and may explain why transgenic mice with DNp63a targeted to the epidermis with the loricrin promoter lack an apparent differentiation phenotype (Liefer et al., 2000) .
Beyond blocking keratinocyte differentiation and p53-mediated transactivation, we demonstrate that DNp63a is capable of positively regulating gene transcription in epidermal keratinocytes, but not in dermal fibroblasts or Saos-2 cells. Consistent with our findings, the selective transactivation of p53-responsive genes by tetracycline-regulated DNp63a was recently noted in the epithelial H1299 carcinoma cell line (Dohn et al., 2001) . Our studies with primary fibroblasts derived from the same skin samples as the keratinocytes eliminate the possibility that the differences observed between cell types are because of species variations, acquired genetic alterations, or variable expression levels. The restricted pattern of p63 expression suggests that it provides a tissue-specific function relevant to the development and maintenance of the basal cell phenotype. The cell-type-specific transactivation by DNp63a may participate in and reflect this role.
It has been proposed that the amino terminal 26 amino acids of DNp63 encode a novel transactivation domain (Dohn et al., 2001; Duijf et al., 2002) , supporting a direct mechanism of gene regulation by DNp63. Consistent with this model, the core DNA binding domain of p63, which is shared across all p63 isoforms, is capable of binding multiple p53 responsive consensus sequences (Klein et al., 2001) , and we showed that mutations in the p53 consensus sequence diminish transactivation levels. However, the temporal delay in transactivation observed with DNp63a in keratinocytes (Figure 5a ) suggests that induction of additional cofactors not available in other cell types may be required. Whether such cofactors cooperate in transactivation by blocking negative regulators of gene transcription or by alleviating inhibition because of the a-carboxy terminus, as suggested by the time course of transactivation by p40 (Figure 5d ), remains unclear. In this context, it is interesting to note that DNp63 has been shown to regulate positively transcription of VEGF as well as b-catenin-dependent transcription via interactions with additional proteins (Senoo et al., 2002; Patturajan et al., 2002) .
The relative contributions of the positive and negative transcriptional regulatory functions of DNp63a to keratinocyte growth regulation and differentiation remain to be elucidated. The activation by DNp63a of the reporter constructs used in this study presumably reflects endogenous gene activity, and current efforts are focused on the identification of downstream targets of DNp63a-mediated transactivation in this keratinocyte model. Microarray analyses have suggested several candidate genes, which will be the subject of future studies (KE King, M Gerdes and WC Weinberg, unpublished observations). Given the potential for interaction among p53 family members (Yang et al., 1998; Davison et al., 1999; Gaiddon et al., 2001; Ratovitski et al., 2001) and the ability of these family members to modulate transcription of multiple genes (Shimada et al., 1999; De Laurenzi et al., 2000; Dohn et al., 2001; Moll et al., 2001) , changes in the relative ratios of p53 homologues could have strong implications for the expression patterns of target genes. The ultimate biological impact of DNp63a overexpression is likely to reflect the specific cell populations targeted, the stage of differentiation of the expressing cell, as well as the balance of additional p53 family members.
Materials and methods

Cell culture
Primary keratinocytes and dermal fibroblasts were isolated from the skin of 1-2 day-old C57B1/6NCr mice as described (Yuspa et al., 1989; Weinberg et al., 1994) . Keratinocytes differing in p53 gene status were isolated from mice ( þ / þ ), ( þ /À), or (À/À) for a null mutation in the p53 gene on a mixed genetic background and genotyped as previously described (Weinberg et al., 1994) .
Freshly isolated keratinocytes were cultured in standard growth medium composed of minimal essential medium (SMEM) (Life Technologies, Gaithersburg, MD, USA), 8% chelexed fetal bovine serum (FBS) (Gemini BioProducts, Calabasas, CA, USA), 10 U/ml penicillin, and 10 mg/ml streptomycin (Life Technologies), at a final concentration of 0.05 mm Ca 2 þ . Differentiation was induced by elevating extracellular [Ca 2 þ ] to 40.1 mm (Yuspa et al., 1989) . Fibroblasts were cultured in standard growth medium containing 1.2 mm Ca 2 þ . In some experiments, 40 mg/ml of the caspase inhibitor Z-VAD-FMK was added to the medium (Enzyme Systems Products, Livermore, CA, USA). Saos-2 cells (American Type Culture Collection, Manassas, VA, USA) were maintained in DMEM (Life Technologies, Gaithersburg, MD, USA) containing 10% newborn calf serum (BioWhittaker, Walkersville, MD, USA).
Adenoviruses
Adenovirus encoding DNp63a was generated by ligating the complete coding region of a DNp63a cDNA clone excised from pThioHis with XhoI into the SalI-site of the shuttle vector pcCMV-pLpA (Becker et al., 1994; Lee et al., 1999) . cDNA orientation was verified via restriction analysis and appropriate constructs were cotransfected with pJM17 into HEK 293 cells by CaPO 4 precipitation for production of recombinant, replication-deficient adenovirus (Becker et al., 1994) . Transgene expression by plaque-purified viruses was confirmed via PCR using the following oligonucleotides: 5 0 -cggtgggaggtctatataagcaga-3 0 and 5 0 -ggtgtcttcattcca-3 0 , and positive viruses were propagated in 293 cells. Control adenoviruses were generated by cotransfection of pJM17 and the parent pcCMVpLpA plasmid. Adenoviruses encoding p53 and b-galactosidase were constructed as described (Ishida et al., 2000) . Adenovirus encoding p40 and a matched control adenovirus were the generous gifts of Dr D Sidransky.
Transient transfections and adenoviral infections
The p53-responsive luciferase reporter constructs PG 13 luc and BDS-2, and the control constructs MG 15 luc and BDS-2 n that contain mutations in the p53 binding sequences (Kern et al., 1991; Hermeking et al., 1997) , were generously provided by Dr B Vogelstein. For reporter gene assays, keratinocytes were plated at a density of 3-6 Â 10 6 cells per 60 mm dish and cultured for 7 days prior to transfection. Fibroblasts and Saos-2 cells were plated 1 day prior to transfections at a density of 1 Â 10 6 cells and 5.7 Â 10 5 cells/60 mm dish, respectively. Transfections were performed with the Lipofectamine Reagent System (Life Technologies) according to the manufacturer's protocol but using 3 mg of DNA and 4 ml PLUS reagent per dish.
For adenoviral-mediated gene transduction, cells were incubated 60 min at 371C in serum-free growth medium containing an equal MOI of the following adenoviral constructs: control vector, b-galactosidase, DNp63a, p53 or p40. Following the incubation, the medium was aspirated and replaced with standard growth medium. For transactivation assays, identical cultures were transfected with the reporter construct; immediately following transfection, cultures were infected with the adenovirus noted.
FACS analysis
Confluent cultures of primary murine keratinocytes were adenovirally infected with Ad-DNp63a or Ad-lacZ at 1.5 days postplating. At 17 h postinfection, the medium was changed and cells were maintained for 24 h in 0.05 or 0.12 mm Ca 2 þ . Cultures were pulsed with 10 mm BrdU for the final 4 h. Cells were fixed in 70% ethanol for 24 h and incubated with an antibody to BrdU as per the manufacturer's protocol (BectonDickinson) followed by incubation with propidium iodide (5 mg/ml). The cell cycle distribution was analysed using Cell Quest software on a Becton Dickinson FACSCalibur. A total of three to six replicates were analysed per condition. Results from each of three independent experiments are presented as the mean % S phase population 7s.d.
Luciferase assays and Western blotting
For transactivation assays, samples were harvested in Reporter Lysis Buffer (Promega Corp., Madison, WI, USA) at 17, 41, or 72 h postadenoviral infection. Protein concentrations were determined using the Protein Assay System (Bio-Rad, Hercules, CA, USA). Equal amounts of protein were analysed using the Luciferase Assay System (Promega Corp., Madison, WI, USA), and luciferase activity was detected using a ML 3000 Microtitre plate luminometer (Dynatech Laboratories, Chantilly, VA, USA) or MicroLumat Plus Microplate Luminometer LB96 V (EG&G Berthold GmbH and Co., Bad Wilbad, Germany). Results shown are from representative experiments and are presented as the mean of relative luciferase units from triplicate samples 7s.d.
For Western analysis, soluble protein lysates and total cell lysates were harvested as described (Weinberg et al., 1995; Veri et al., 2001) . Optitran nitrocellulose membranes (Schleicher and Scheull, Keene, NH, USA) were probed with the following antibodies: murine monoclonal anti-p63 (4A4, Santa Cruz Biotechnology, Santa Cruz, CA, USA); murine monoclonal anti-a-actin (Sigma Immuno Chemicals, St Louis, MO, USA); rabbit anti-keratins 1, 10, 14 and rabbit anti-filaggrin (BABCO, Richmond, CA, USA). Signal was detected using horseradish peroxidase linked anti-mouse or anti-rabbit Ig secondary antibody and enhanced chemiluminescence (ECL, Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Abbreviations b-gal, b-galactosidase; DMEM, Dulbecco's modified Eagle's medium; MOI, multiplicity of infection; Ad-DNp63a, overexpression of DNp63a mediated by adenovirus.
